UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

Healthcare Utilization in Obese Caregiver Living Donors

Completed

Conditions: Obesity
Utilization, Health Care

Interventions: Other: Caregivers
Other: Non-caregivers

First Posted Date: 2020-04-10

Last Posted Date: 2024-12-16

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 784

Registration Number: NCT04341896

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction

Phase 1

Active, not recruiting

Conditions: Breast Benign Tumor
Breast Malignant Tumor

Interventions: Drug: Standard of Care (SOC) gadolinium Breast MRI
Drug: reduced 1/4 dose gadolinium Breast MRI with Artificial Intelligence (AI) to aid in evaluation.

First Posted Date: 2020-04-09

Last Posted Date: 2024-03-28

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 20

Registration Number: NCT04340180

Locations: 🇺🇸
The Kirklin Clinic, Birmingham, Alabama, United States

Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients

Phase 2

Withdrawn

Conditions: COVID19

Interventions: Drug: Tranexamic acid
Drug: Placebo oral tablet

First Posted Date: 2020-04-08

Last Posted Date: 2021-04-23

Lead Sponsor: University of Alabama at Birmingham

Registration Number: NCT04338126

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Exclusive Enteral Nutrition in Preterm Neonates

Not Applicable

Active, not recruiting

Conditions: Enteral Feeding Intolerance
Premature; Infant, Light-for-dates

Interventions: Procedure: Exclusive Enteral Nutrition
Procedure: Progressive Enteral Nutrition

First Posted Date: 2020-04-08

Last Posted Date: 2024-01-05

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 102

Registration Number: NCT04337710

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

TXA and Corona Virus 2019 (COVID19) in Outpatients

Phase 2

Terminated

Conditions: COVID-19

Interventions: Drug: Tranexamic acid tablets
Drug: Placebo oral tablet

First Posted Date: 2020-04-08

Last Posted Date: 2021-05-13

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 5

Registration Number: NCT04338074

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Influence of Obesity on Oxalate Metabolism and Handling in Calcium Oxalate Stone Formers

Not Applicable

Active, not recruiting

Conditions: Kidney Stone

Interventions: Other: Controlled Diet
Dietary Supplement: Carbon-13 Oxalate and Sucralose Ingestion

First Posted Date: 2020-04-03

Last Posted Date: 2024-12-16

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 22

Registration Number: NCT04333745

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI

Phase 1

Recruiting

Conditions: HER2-positive Breast Cancer

Interventions: Drug: [18F]FMISO PET/MRI imaging

First Posted Date: 2020-04-02

Last Posted Date: 2024-04-25

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 25

Registration Number: NCT04332588

Locations: 🇺🇸
The University of Alabama at Birmingham, Birmingham, Alabama, United States

Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits

Not Applicable

Active, not recruiting

Conditions: Glaucoma
Diabetic Retinopathy
Cataract
Refractive Errors
Behavior, Health

Interventions: Other: No Financial Incentive
Behavioral: Financial Incentive

First Posted Date: 2020-03-31

Last Posted Date: 2024-04-15

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 1000

Registration Number: NCT04328207

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk

Not Applicable

Active, not recruiting

Conditions: Breast Milk Expression
Microbial Colonization
Prematurity; Extreme
Feeding Disorder Neonatal
Growth Failure

Interventions: Procedure: Usual human milk diet
Procedure: Protein-enriched human milk diet

First Posted Date: 2020-03-27

Last Posted Date: 2024-03-13

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 150

Registration Number: NCT04325308

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

A Trial to Assess the Safety and Efficacy of KRN23 in Epidermal Nevus Syndrome (ENS)

Phase 4

Completed

Conditions: Epidermal Nevus Syndrome

Interventions: Drug: Crysvita (burosumab-twza) Treatment

First Posted Date: 2020-03-25

Last Posted Date: 2022-10-07

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 1

Registration Number: NCT04320316

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Home Terms & Conditions Privacy Policy